Author Affiliations: Service de Réanimation Polyvalente, Centre Hospitalier Universitaire de La Réunion, Saint Denis, France.
De Luca and colleagues1 concluded from their meta-analysis that drug-eluting stents (DES) in the ST-elevated myocardial infarction (STEMI) setting are more efficient than bare-metal stents (BMS) in reducing target-vessel revascularization (TVR). One must remember that during STEMI, one of the most serious complications is cardiogenic shock, which is not well pinpointed in their study.
Champion S, Gaüzère BA, Lefor Y. Drug-Eluting Stents Should Not Be Used in ST-Elevated Myocardial Infarction With Cardiogenic Shock. Arch Intern Med. 2012;172(20):1613–1614. doi:10.1001/archinternmed.2012.4418
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: